What is the official website of Enclara Pharmacia ?

The official website of Enclara Pharmacia is https://enclarapharmacia.com/.

What is Enclara Pharmacia's cybersecurity risk score?

Enclara Pharmacia has an AI-generated cybersecurity risk score of 755 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Enclara Pharmacia experienced?

According to Rankiteo, Enclara Pharmacia currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Enclara Pharmacia been affected by any supply chain cyber incidents ?

According to Rankiteo, Enclara Pharmacia has been affected by a supply chain cyber incident involving Future Cardia, with the incident ID HUMORAHEACEN1774290394.

Does Enclara Pharmacia have SOC 2 Type 1 certification ?

According to Rankiteo, Enclara Pharmacia is not certified under SOC 2 Type 1.

Does Enclara Pharmacia have SOC 2 Type 2 certification ?

According to Rankiteo, Enclara Pharmacia does not hold a SOC 2 Type 2 certification.

Does Enclara Pharmacia comply with GDPR ?

According to Rankiteo, Enclara Pharmacia is not listed as GDPR compliant.

Does Enclara Pharmacia have PCI DSS certification ?

According to Rankiteo, Enclara Pharmacia does not currently maintain PCI DSS compliance.

Does Enclara Pharmacia comply with HIPAA ?

According to Rankiteo, Enclara Pharmacia is not compliant with HIPAA regulations.

Does Enclara Pharmacia have ISO 27001 certification ?

According to Rankiteo,Enclara Pharmacia is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Enclara Pharmacia operate in ?

Enclara Pharmacia operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does Enclara Pharmacia have ?

Enclara Pharmacia employs approximately 525 people worldwide.

Does Enclara Pharmacia own any subsidiaries ?

Enclara Pharmacia presently has no subsidiaries across any sectors.

How many LinkedIn followers does Enclara Pharmacia have ?

Enclara Pharmacia's official LinkedIn profile has approximately 7,330 followers.

What is the NAICS classification code for Enclara Pharmacia ?

Enclara Pharmacia is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does Enclara Pharmacia have a Crunchbase profile ?

Yes, Enclara Pharmacia has an official profile on Crunchbase, which can be accessed here: https://www.crunchbase.com/organization/enclara-health.

Does Enclara Pharmacia have a LinkedIn profile ?

Yes, Enclara Pharmacia maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/enclara-pharmacia.

How many cybersecurity incidents has Enclara Pharmacia experienced ?

As of June 18, 2026, Rankiteo reports that Enclara Pharmacia has experienced 9 cybersecurity incidents.

How many peer or competitor companies does Enclara Pharmacia have ?

Enclara Pharmacia has an estimated 5,692 peer or competitor companies worldwide.

What types of cybersecurity incidents has Enclara Pharmacia faced ?

Incident Types: The types of cybersecurity incidents that have occurred include Ransomware, Breach and Cyber Attack.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

Enclara Pharmacia

Boost Score +25 with badge (5 left)

755

/1000

Fair

780

/1000

Fair

Enclara Pharmacia Vendor Cyber Rating & Cyber Score

enclarapharmacia.com

cb in

Add Your Compliance Badge

As the nation’s leading pharmacy solutions provider for the hospice and palliative care community, Enclara Pharmacia empowers people to transform hospice care through collaboration, creativity, and compassion. Through a comprehensive network of retail and institutional pharmacies, a national patient-direct dispensing program and dedicated inpatient services, Enclara ensures timely and reliable medication access in any care setting. Combining clinical expertise, proprietary technology and a patient-focused, nurse-centric approach, Enclara enables hospices of all sizes and models to improve quality of life for individuals experiencing progressive illness. You Deliver the Care. We Make It Easier. For more information, visit

Enclara Pharmacia A.I CyberSecurity Scoring

Scoring History

Enclara Pharmacia

Enclara Pharmacia CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

Humana

Ransomware

100

8/2025

Future Cardia

HUMORAHEACEN177...

Enclara Pharmacia

Breach

8/2023

HUM143072625

Enclara Pharmacia

Cyber Attack

5/2023

HUM030090625

Enclara Pharmacia

Breach

09/2022

HUM232025922

Enclara Pharmacia

Breach

5/2022

HUM033091825

Enclara Pharmacia

Ransomware

100

4/2021

HUM511080425

Enclara Pharmacia

Breach

10/2020

HUM806072625

Enclara Pharmacia

Breach

5/2018

HUM1046072525

Enclara Pharmacia

Breach

02/2018

CAR10557622

Loading…

A.I.

Enclara Pharmacia Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for Enclara Pharmacia

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Enclara Pharmacia in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Enclara Pharmacia in 2026.

Incident Types Enclara Pharmacia vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Enclara Pharmacia in 2026.

Incident History - Enclara Pharmacia (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Enclara Pharmacia Subsidiaries

Enclara Pharmacia

Pharmaceutical Manufacturing

Website: https://enclarapharmacia.com/

Company Size: 525

HumanaInsurance

Humana FoundationPhilanthropy

OneHomeHospitals and Health Care

Conviva Senior Primary CareHospitals and Health Care

Harris Rothenberg InternationalHealth, Wellness & Fitness

Arcadian Health PlanHospitals and Health Care

CarePlus Health PlansInsurance

Loading…

Enclara Pharmacia Similar Companies

Servier

servier.com

Founded to serve health 70 years ago, Servier is a global pharmaceutical group governed by a non-profit Foundation that aspires to make a meaningful social impact for patients and for a sustainable world. The Group’s unique governance model preserves its independence and means it can fully serve its vocation of being committed to therapeutic progress to serve patient needs while adopting a long-term vision. Its employees are fully committed to this shared vocation, which serves as a source of inspiration every day. A world leader in cardiometabolism and venous diseases, Servier has made a major shift into oncology, which represents a new pillar of strategic growth. The Group devotes close to 70% of its R&D budget to this field, with the ambition of becoming a focused and innovative player in the development of treatments targeting rare cancers. Neurology will constitute a future growth driver. Servier is focusing on a limited number of diseases in this area where accurate patient profiling makes it possible to offer a targeted therapeutic response through precision medicine. To promote widespread access to quality care at a lower cost, the Group also offers a range of quality generic drugs covering most pathologies, leveraging well-known brands in France, and Eastern Europe. In all these areas, the Group takes patient considerations into account at every stage of the medicine life cycle. Headquartered in France, Servier relies on committed teams and strong geographical footprint; its medicines are available in close to 140 countries. In 2023/2024, the Group achieved sales revenue of €5.9 billion and EBITDA of €1.3 billion in 2024 (22.2%). Today, the Group employs over 22,000 people worldwide. -- To report a suspected adverse event with a Servier drug, please visit servier.com

MSD

msd.com

At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.msd.com and connect with us on Facebook, Instagram, Twitter, and YouTube.

Sandoz

sandoz.com

Sandoz is the global leader in generic and biosimilar medicines. Our Purpose is to pioneer access to medicines for patients globally. We are on a mission to drive innovation in the healthcare industry by freeing up resources sustainably and responsibly while continuing to address global health challenges such as antimicrobial resistance. We are present in more than 100 countries and our medicines serve some 500 million people every year. We have two main global businesses: Generics - divided between standard generics and complex generics - and Biosimilars. Read our community engagement guidelines: http://bit.ly/4ofoggc

Merck

merck.us

At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.merck.com. This site is intended for residents of the United States and Canada and their territories only. FLS: http://merck.us/3TKXNuZ

Eli Lilly and Company

lilly.com

We're a medicine company turning science into healing to make life better for people around the world. It all started nearly 150 years ago with a clear vision from founder Colonel Eli Lilly: "Take what you find here and make it better and better." Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing science to solve some of the world's most significant health challenges. General Information and Guidelines: When you engage with us on LinkedIn, you're agreeing to these Community Guidelines: https://e.lilly/guidelines. If you have questions about a Lilly medicine, contact The Lilly Answers Center at 1-800-Lilly-Rx (1-800-545-5979) Monday through Friday, excluding company holidays.

Torrent Pharmaceuticals Ltd

cb torrentpharma.com

Torrent Pharma, with annual revenues of more than Rs 10,700 crores, is the flagship Company of the Torrent Group, with group revenues of Rs 41,000 crores. It is ranked 5th in the Indian Pharma Market and is among the Top 5 in the therapeutic segments of Cardiovascular (CV), Central Nervous System (CNS), Gastro-intestinal (GI), Vitamins Minerals Nutritionals (VMN) and Cosmo-Dermatology. The Company also has significant presence in diabetology, pain management, gynaecology, oncology and anti-infective segments. Torrent has 8 manufacturing facilities , of which 5 are USFDA approved. With R&D as the backbone for its growth in domestic & overseas market, it has invested significantly in R&D capabilities with state-of-the-art R&D infrastructure employing around 800 scientists. The acquisition of Elder Pharma's Indian branded business in 2013, Dermaceuticals business of Zyg Pharma in 2015, API plant of Glochem Industries in 2016, Women healthcare brands from Novartis and Unichem's Indian branded business along with its Sikkim Plant in 2017 strengthened Torrent Pharma's position in the Indian Pharma market. Torrent Pharma started international acquisitions in 2005 with entry into the German market. Today, the Company has presence in more than 50 countries and is ranked No. 1 among the Indian pharma Companies in Brazil and Germany. Torrent Pharma is committed towards “not just healthcare but lifecare.”

Teva Pharmaceuticals

tevapharm.com

Teva Pharmaceuticals is a leading innovative biopharmaceutical company, enabled by a world-class generics business. For over 120 years, Teva’s commitment has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicines, biosimilars and pharmacy brands worldwide, Teva is dedicated to addressing patients’ needs, now and in the future. At Teva, We Are All In For Better Health. To learn more about how we make it happen, visit www.tevapharm.com. Our community guidelines may be found here: https://www.tevapharm.com/news-and-media/teva-social-media-guidelines/ Please note that adverse effects for any of our products should be reported at: https://www.tevapharm.com/teva-medical-information/report-a-side-effect-form/ Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details and Teva's Pharmacovigilance Privacy Policy may be found here: http://www.tevapharm.com/contact_us/

Takeda

cb takeda.com

We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society. We know that changing lives requires us to do things differently. We start by listening to and addressing what really matters to patients, the people who love them, and those in the healthcare system who provide care. And that’s what inspires us all to be bold, push boundaries and set new standards that open up greater opportunities. Read our community guidelines: https://takeda.info/communityguidelines

Zydus Group

zyduslife.com

The Zydus Group with an overarching purpose of empowering people with freedom to live healthier and more fulfilled lives, is an innovative, global life-sciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies. The group employs over 27000 people worldwide and is driven by its mission to unlock new possibilities in life-sciences through quality healthcare solutions that impact lives. The group aspires to transform lives through pathbreaking discoveries.

Loading…

NEWS

Enclara Pharmacia CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

July 30, 2025 07:00 AM

Enclara Pharmacia and FireNote develop new feature to enhance hospice operations

The enhancement enables new FireNote clients to directly download patient medication profiles from Enclara into FireNote's system.

Read Article

April 09, 2025 07:00 AM

Enclara Pharmacia Launches Next-Day Shipping Infusion Services to Support Hospice Providers

PHILADELPHIA, April 09, 2025--Enclara Pharmacia, the nation's leading hospice pharmacy solutions provider, has announced the launch of...

Read Article

December 16, 2019 08:00 AM

Humana to Acquire Enclara Healthcare

LOUISVILLE, KY and PHILADELPHIA, PA (December 16, 2019) – Humana Inc. (NYSE: HUM) today announced it has signed a definitive agreement to acquire privately...

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-48777

SUMMARY

FileBrowser Quantum is a free, self-hosted, web-based file manager. Versions prior to 1.3.2-stable, 1.4.0-beta and 1.4.1-beta are vulnerable to Path Traversal through the publicPatchHandler in backend/http/public.go which joins user-controlled fromPath and toPath body fields with the trusted d.share.Path BEFORE the downstream sanitizer runs. Because filepath.Join collapses .. segments during the join, the sanitizer in resourcePatchHandler never sees the traversal and the move/copy/rename operates on a path outside the shared directory. The same root-cause pattern was patched for the bulk DELETE endpoint as CVE-2026-44542 (GHSA-fwj3-42wh-8673), but the PATCH handler with the identical pattern was not updated. A public share link with AllowModify=true is sufficient to exploit this. Anyone holding such a link can move, copy, or rename arbitrary files within the share owner's source root. This issue has been fixed in versions 1.3.3-stable and 1.4.2-beta.

Published

Date2026-06-16

Updated

Date2026-06-16

RISK INFORMATION (Score: )

cvss4

Base Score: 9.3

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

CVE-2026-47750

SUMMARY

stable-diffusion.cpp is a pure C/C++ library for running diffusion model (Stable Diffusion, Flux, Wan, Qwen Image, Z-Image, and more) inference. In versions prior to master-584-0a7ae07, the pickle .ckpt parser in src/model.cpp contained a heap buffer overflow vulnerability in the GLOBAL opcode handler. The issue was caused by missing validation when searching for newline-delimited fields. A crafted .ckpt file without the expected newline could cause the parser to use -1 as a copy length, resulting in immediate heap corruption. The attack requires the victim or application to load a .ckpt file from an untrusted source, such as a downloaded model from a model sharing site. The issue has been resolved in version master-584-0a7ae07. If developers are unable to immediately update their applications they can work around this issue by following these instructions: do not load .ckpt checkpoint files from untrusted sources, and prefer trusted model sources and safer formats such as .safetensors where possible.

Published

Date2026-06-16

Updated

Date2026-06-16

RISK INFORMATION (Score: 7.8)

cvss3

Base Score: 7.8

Complexity: LOW

CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H

Impact Score

5.9

Exploitability

1.8

REFERENCES

CVE-2026-47747

SUMMARY

stable-diffusion.cpp is a pure C/C++ library for running diffusion model (Stable Diffusion, Flux, Wan, Qwen Image, Z-Image, and more) inference. In versions prior to master-584-0a7ae07, the pickle .ckpt parser in src/model.cpp contained a heap buffer overflow vulnerability in the BINUNICODE opcode handler. The issue was caused by sign confusion on the opcode length field. A crafted .ckpt file could trigger memcpy with a very large length derived from a negative signed value, causing immediate heap corruption. The issue has been resolved in version master-584-0a7ae07. If developers are unable to immediately update their applications they can work around this issue by only loading .ckpt checkpoint files from trusted sources and preferring trusted model sources and safer formats such as .safetensors where possible.

Published

Date2026-06-16

Updated

Date2026-06-16

RISK INFORMATION (Score: 7.8)

cvss3

Base Score: 7.8

Complexity: LOW

CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H

Impact Score

5.9

Exploitability

1.8

REFERENCES

CVE-2026-46448

SUMMARY

In OpenStack Nova before 33.0.2, the server create API does not strip certain hint data. The resulting instance has no Placement allocation.

Published

Date2026-06-16

Updated

Date2026-06-16

RISK INFORMATION (Score: 5.4)

cvss3

Base Score: 5.4

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:L

Impact Score

2.5

Exploitability

2.8

REFERENCES

CVE-2026-22313

SUMMARY

The device has a webserver that exposes a REST API authenticated with a token on the management network. By exploiting an OS command injection vulnerability an authenticated attacker can send arbitrary commands to the device that are executed with administrative permissions by the underlying operating system.

Published

Date2026-06-16

Updated

Date2026-06-16

RISK INFORMATION (Score: 9.1)

cvss3

Base Score: 9.1

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:C/C:H/I:H/A:H

Impact Score

Exploitability

2.3

REFERENCES

https://www.cvcn.gov.it/cvcn/cve/CVE-2026-22313

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…